1. A novel analytical framework for risk stratification of real‐world data using machine learning: A small cell lung cancer study. Issue 10 (29th July 2022) Authors: Marzano, Luca; Darwich, Adam S.; Tendler, Salomon; Dan, Asaf; Lewensohn, Rolf; De Petris, Luigi; Raghothama, Jayanth; Meijer, Sebastiaan Journal: Clinical and translational science Issue: Volume 15:Issue 10(2022) Page Start: 2437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib. Issue 3 (28th September 2016) Authors: Morcos, Peter N.; Cleary, Yumi; Guerini, Elena; Dall, Georgina; Bogman, Katrijn; De Petris, Luigi; Viteri, Santiago; Bordogna, Walter; Yu, Li; Martin‐Facklam, Meret; Phipps, Alex Journal: Clinical pharmacology in drug development Issue: Volume 6:Issue 3(2017) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden" [Lung Cancer 120 (June) (2018) 75–81]. (September 2018) Authors: Tendler, Salomon; Grozman, Vitali; Lewensohn, Rolf; Tsakonas, Georgios; Viktorsson, Kristina; De Petris, Luigi Journal: Lung cancer Issue: Volume 123(2018) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study. (January 2020) Authors: Tendler, Salomon; Holmqvist, Marit; Wagenius, Gunnar; Lewensohn, Rolf; Lambe, Mats; De Petris, Luigi Journal: Lung cancer Issue: Volume 139(2020) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors. (March 2021) Authors: Skribek, Marcus; Rounis, Konstantinos; Afshar, Soren; Grundberg, Oscar; Friesland, Signe; Tsakonas, Georgios; Ekman, Simon; De Petris, Luigi Journal: European journal of cancer Issue: Volume 145(2021) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression. (October 2018) Authors: Hydbring, Per; De Petris, Luigi; Zhang, Yanming; Brandén, Eva; Koyi, Hirsh; Novak, Metka; Kanter, Lena; Hååg, Petra; Hurley, James; Tadigotla, Vasisht; Zhu, Baoli; Skog, Johan; Viktorsson, Kristina; Ekman, Simon; Lewensohn, Rolf Journal: Lung cancer Issue: Volume 124(2018) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing. (September 2020) Authors: Svedberg, Anna; Björn, Niclas; Sigurgeirsson, Benjamín; Pradhananga, Sailendra; Brandén, Eva; Koyi, Hirsh; Lewensohn, Rolf; De Petris, Luigi; Apellániz-Ruiz, María; Rodríguez-Antona, Cristina; Lundeberg, Joakim; Gréen, Henrik Journal: Lung cancer Issue: Volume 147(2020) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Multiplex immune protein profiling of fine‐needle aspirates from patients with non‐small‐cell lung cancer reveals signatures associated with PD‐L1 expression and tumor stage. Issue 11 (1st May 2021) Authors: Franzén, Bo; Viktorsson, Kristina; Kamali, Caroline; Darai‐Ramqvist, Eva; Grozman, Vitali; Arapi, Vasiliki; Hååg, Petra; Kaminskyy, Vitaliy O.; Hydbring, Per; Kanter, Lena; Nyrén, Sven; Ekman, Simon; De Petris, Luigi; Lewensohn, Rolf Journal: Molecular oncology Issue: Volume 15:Issue 11(2021) Page Start: 2941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer. (January 2020) Authors: Ou, Sai-Hong Ignatius; Gadgeel, Shirish M.; Barlesi, Fabrice; Yang, James Chih-Hsin; De Petris, Luigi; Kim, Dong-Wan; Govindan, Ramaswamy; Dingemans, Anne-Marie; Crino, Lucio; Léna, Hervé; Popat, Sanjay; Ahn, Jin Seok; Dansin, Eric; Mitry, Emmanuel; Müller, Barbara; Bordogna, Walter; Balas, Bogda... Journal: Lung cancer Issue: Volume 139(2020) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes. Issue 4 (14th February 2022) Authors: Björn, Niclas; Jakobsen, Ingrid; Udagawa, Chihiro; Brandén, Eva; Koyi, Hirsh; Lewensohn, Rolf; De Petris, Luigi; Zembutsu, Hitoshi; Gréen, Henrik Journal: Basic & clinical pharmacology & toxicology Issue: Volume 130:Issue 4(2022) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗